Preoperative prediction of multifocal prostate cancer and application of focal therapy: review 2007

  • Meiers I
  • Waters D
  • Bostwick D
  • 4


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Prostate cancer is a leading malignancy among men. Early prostate cancer is most commonly treated with radical surgery and radiotherapy. In the era of prostate-specific antigen and newly emerging highly specific screening tests, a greater number of men are given a diagnosis earlier in life, and disease is more often confined. Less-invasive treatments, such as focal therapy, are becoming increasingly popular, yielding shorter hospital stays, faster recovery, and fewer complications. Potential drawbacks to focal therapy include the risk of incomplete treatment, which may result from missed cancer foci and inadequate ablation to target tissues. Furthermore, this approach is not universally applicable to all patients--for example, those who have periurethral and extraprostatic extension of the tumor may not benefit from focal treatment. This article reviews the importance of multifocal prostate cancer and the application of focal treatment.

Author-supplied keywords

  • Biopsy
  • Humans
  • Male
  • Medical Oncology/*methods
  • Prognosis
  • Prostate-Specific Antigen/blood
  • Prostate/pathology
  • Prostatectomy
  • Prostatic Neoplasms/*diagnosis/*therapy
  • Risk

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in


  • I Meiers

  • D J Waters

  • D G Bostwick

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free